Form 4: Relay Therapeutics Officer Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Peter Rahmer, Chief Corporate Development Officer of Relay Therapeutics, sold 245 shares of common stock on September 27, 2024, to cover income tax withholding obligations upon the vesting of restricted stock units.
Summary
- Peter Rahmer, Chief Corporate Development Officer of Relay Therapeutics, sold 245 shares of common stock on September 27, 2024.
- The sale was executed at a price of $7.51 per share.
- The transaction was to cover income tax withholding obligations upon the vesting of 992 shares of restricted stock units (RSUs) on September 26, 2024.
- Following the transaction, Rahmer beneficially owns 391,684 shares, including 376,945 shares underlying RSUs.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing related to an insider stock sale for tax purposes. It doesn't convey any particularly positive or negative sentiment about the company's performance or outlook.
Industry Context
This is a routine Form 4 filing, reflecting an insider transaction related to tax obligations on vested equity. Such filings are common and provide transparency into insider activity, but do not necessarily indicate a change in the company's prospects.
Key Dates
| Date | Description |
|---|---|
| 09/26/2024 | Vesting of 992 shares of restricted stock units. |
| 09/27/2024 | Sale of 245 shares of common stock by Peter Rahmer. |
| 10/01/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.